- AD5-nCOV, trade-named
Convidecia, is a single-dose
viral vector vaccine for COVID-19 that is also used as an
inhaled booster. It was
developed by CanSino...
- Oxford–AstraZeneca,
Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax,
Convidecia, and Sanofi–GSK.
Seven others are
under ****essment by the WHO: Sputnik...
- US
Vaccine card
Vaccine p****ports
Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm...
-
vaccines were two-dose vaccines, with the
exception single-dose
vaccines Convidecia and the
Janssen COVID‑19 vaccine, and
vaccines with three-dose schedules...
-
vaccines were two-dose vaccines, with the
exception single-dose
vaccines Convidecia and the
Janssen COVID‑19 vaccine, and
vaccines with three-dose schedules...
- US
Vaccine card
Vaccine p****ports
Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm...
- US
Vaccine card
Vaccine p****ports
Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm...
- US
Vaccine card
Vaccine p****ports
Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm...
- US
Vaccine card
Vaccine p****ports
Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm...
-
later worked together to
develop an
Ebola vaccine. AD5-nCOV, trade-named
Convidecia, is a single-dose
viral vector COVID-19
vaccine developed by CanSino....
